Dianthus Therapeutics | Üzemi Eredmény



Operating Profit változás Dátum
Adcock Ingram Holdings ZAR 479.08M 106.67M 2024-06
Alaunos Therapeutics USD -1150000 16K 2024-09
Avita Medical AUD -9957000 5.64M 2024-12
Celltrion KRW 207.69B 135.2B 2024-09
Cspc Pharmaceutical CNY 985M 796.94M 2024-09
Dianthus Therapeutics USD -29900000 7.7M 2024-09
Ecofibre AUD -4680000 38.98M 2024-06
IQVIA Holdings USD 626M 76M 2024-12
Kangmei Pharma CNY -58945310 67.51M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 37.16M 17.88M 2024-06
Malin Corporation EUR -700000 1.6M 2024-06
Medical Developments International AUD -20243000 7.24M 2024-06
Moderna USD -1246000000 1.18B 2024-12
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Organon & Co USD 129M 78M 2024-12
Pharma Mar EUR 4.89M 588K 2024-12
Qiagen NV USD 144.16M 14.73M 2024-12
Revvity USD 118.75M 20.6M 2024-12
Sartorius EUR 68.2M 38.1M 2024-09
Sino Biopharmaceutical CNY 1.73B 948.23M 2024-06
Tectonic Therapeutic USD -19637000 8.22M 2024-09
Tilray USD -42218000 5.65M 2024-11
Viatris USD -17900000 307.3M 2024-12
Xeris Pharmaceuticals USD -12893000 4.71M 2024-09
Zz Pientze Pharmaceu 1.13B 233.14M 2024-09



Dianthus Therapeutics Üzemi Eredmény - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.